维普中文期刊产品整合服务
46篇 您的检索式:作者名="Rini G"
    题名 作者 年代 出处 被引量
1Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella 2011The Lancet . 2011 (9807)2011,,9807:2
2Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial显示文摘Brian I Rini Bernard Escudier Piotr Tomczak Andrey Kaprin Cezary Szczylik Thomas E Hutson M Dror Michaelson Vera A Gorbunova Martin E Gore Igor G Rusakov Sylvie Negrier Yen-Chuan Ou Daniel Castellano Ho Yeong Lim Hirotsugu Uemura Jamal Tarazi David Cella 2011The Lancet2011,,9807:2
3Phase I1 study of axitinib in sorafenib-reffactory metastatic renal cell carcinoma 显示文摘Rini BI Wilding G Hudes G 2009J Clin Oncol2009,27,27:1
4Kinetic aspects of the glass transition behavior of maltose-water mixtures显示文摘Noel T R Riny S G Whittam M A 1991Carbohydrates Research1991,,212:1
5Local interleukin-10 production during respiratory syncytial virus bronchiolitis is associatedwith post-bronchiolitis wheeze显示文摘Annemieke S Riny J Haunekede G 2011Respir Res2011,12,1:1
6Phase II study ofaxitinib in sorafenib - refactory metastatic reanl cell carcinoma 显示文摘Rini HI Wilding G Hudes G 2009J Clin Oncol2009,27,27:1
7Axitinib ( AG- 013736; AG) in patients with metastatic renal cell cancer (RCC) refractory to sorafenib 显示文摘Rini BI Wilding GT Hudes G 2007J Clin Oncol (Meeting Abstracts)2007,25,18:1
8Statins, fracture risk,and boneremodeling: what is true? 显示文摘RIZZO M RINI G B 2006The American journal of themedical sciences2006,332,2:1
9Phase Ill study of axitinib in sorafenib-refractory metastatic renal cell carcinoma 显示文摘Rini BI Wilding G Hudcs G 2009J Clin Onco12009,27,27:1
10Antigen-presenting cells 8 015 (Provenge) in patinets with and rogen-dependent, biochemically relapsed prostate cancer显示文摘Beinart G Rini BI Weinberg V 2005Clin Prostate Cancer2005,4,1:1
11Axitinib for renal cell carcinoma 显示文摘Sonpavde G Huston TE Rini BI 2008Ixpert Opin Investig Drugs2008,17,5:1
12Axitinib for renal cell carcinoma显示文摘Sonpavde G Hutson TE Rini BI 0,,05:1
13Antigen- presenting cells 8015(Provenge)in patients with androgen-dependent, biochemically relapsed prostate cancer显示文摘Beinart g Rini BI Weinberg V 2005ClinProstate Cancer2005,4,1:1
14Axitinib for renal cell carcinoma 显示文摘Sonpavde G Huston TE Rini BI 2008Ixpert Opin Investig Drugs2008,17,5:1
15Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma显示文摘RINI B WILDING G HUDES G 2009J Clin Oncol2009,27,27:1
16Porphyria cutanea tank,C282Y,H63D and S65C HFE gene mutations and hepatitis C infection:a study from southern France显示文摘Chiavérini C Halimi G Ouzan D 2003Dermatology2003,206,3:1
17Phase II study of axitinib in sorafenib-refractory metastatic renal cell carcinoma显示文摘RINI B I WILDING G HUDES G 2009J Clin Oncol2009,27,27:1
18MMP - 2, MMP - 9 and activin A blood levels in patients with breast cancer or prostate cancer metastatic to the bone 显示文摘Incorvaia L Badalamenti G Rini G 2007Anticancer Res2007,27,3:1
19Prevalence of hypovitaminosis D in elderly women in Italy : clinical consequences and risk factors显示文摘Isaia G Giorgino R Rini GB 20030steoporos Int2003,14,7:1
20Two novel mutations at exon 8 of the Sequestosome 1(SQSTM1)gene in an Italian series of patients affected by Paget's disease of bone(PDB)显示文摘Falchetti A Di Stefano M Marini F Del Monte F Mavilia C Sttigoli D De Feo M L lsaia G Masi L Amedei A Cioppi F Ghinoi V Bongi S M Di Fede G Sferrazza C Rini G B Melchiorre D MatucciCerinic M Brandi M L 0,,06:1
返回顶部 每页显示:
共3页 首页 上一页 第1页 下一页 末页 /3 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费